acquired
Stage
About
SageRx was a biopharmaceutical company focused on developing and commercializing treatments for central nervous system (CNS) diseases. It has been acquired by Supernus Pharmaceuticals.
Explore SageRx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.